base metals investing Ardelyx Reports Third Quarter 2026 Financial Results and Provides Business Update
base metals investing Ardelyx Completes Enrollment in Phase 3 ACCEL Clinical Trial of IBSRELA® in Adults with Chronic Idiopathic Constipation
base metals investing Ardelyx Presents Real-World Data at ASN Kidney Week 2026 Showing Serum Phosphate Reductions Following XPHOZAH® Initiation With or Without Phosphate Binders
base metals investing Ardelyx Presents Real-World Data at ACG 2026 Showing Reduced Healthcare Resource Utilization Following IBSRELA® Initiation in Adults with IBS-C
base metals investing Ardelyx Presents Analysis Supporting Long-Term Safety of XPHOZAH at NKF's Spring Clinical Meetings
base metals investing Ardelyx Reports First Quarter 2026 Financial Results and Provides Business Update
base metals investing Ardelyx Announces Abstract Accepted for Poster Presentation at the NKF's Spring Clinical Meetings
base metals investing Ardelyx Announces Abstract Exploring IBS-C Treatment Patterns Accepted for Poster Presentation at Digestive Disease Week 2026
Michael Gentile Announces Filing of Early Warning Report Related to Acquisition of Common Shares of Cascadia Minerals Ltd.